Does surgery for breast cancer induce angiogenesis and thus promote metastasis?

Abstract

At the time of surgery for breast cancer, cancer cells released from the primary tumor have most likely entered blood or lymphatic vessels, leading to the development of micrometastases. Cancer cells directly produce angiogenesis stimulators, provoke the release of stimulators bound to the surrounding extracellular matrix and induce macrophages to secrete angiogenesis stimulators, thereby promoting angiogenesis. Metastasis dormancy is characterized by a balance between cell proliferation and apoptosis and is thought to be controlled by increased apoptosis, indirectly induced by angiogenesis inhibitors. Many patients with solid tumors already have micrometastases at the time of detection and surgical removal of their primary tumors. Primary tumor resection is believed to stimulate angiogenesis, initiating the proliferation of latent micrometastases. Latent micrometastases have already acquired angiogenic potential. The provision of additional therapy to inhibit angiogenesis after surgery is therefore considered a rational approach. The effectiveness of dormancy therapy should be evaluated in the prospective clinical trials of chemotherapy with drugs such as cyclophosphamide and UFT, which have been reported to inhibit angiogenesis as demonstrated by the numbers of circulating endothelial cells and circulating endothelial progenitors in peripheral blood before and after surgery in women with primary breast cancer.

• Authors: Youngjin Park, Tomoaki Kitahara, Ryuichi Takagi, Ryoji Kato
• Journal: Oncology (Oncology) Vol. 81 Issue 3-4 Pg. 199-205 ( 2011) ISSN: 1423-0232 [Electronic] Switzerland
• PMID: 22067898 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2011 S. Karger AG, Basel.

Topics

• Animals
• Breast Neoplasms (blood supply, pathology, surgery)
• Female
• Humans
• Neoplasm Micrometastasis
• Neovascularization, Pathologic (pathology)